alias:: Acute sore throat, Acute pharyngotonsillitis
ICD-11_Code:: CA03.0 (Acute tonsillitis), CA03.1 (Streptococcal tonsillitis)
tags:: disease, inflammatory disease, throat, ent

- ## Etiology
  background-color:: blue
	- ### Causative Agents
		- Virus(70-80%)
			- Adenovirus
			- Rhinovirus
			- Influenza virus
			- Epstein-Barr virus(EBV)
			- Coxsackievirus(Herpangina)
		- Bacterial(20-30%)
			- Group A β-hemolytic Streptococcus (GAS, *S. pyogenes*) (Most common bacterial cause)
			- *Staphylococcus aureus*
			- *Haemophilus influenzae*
			- *Moraxella catarrhalis*
	- ### 3 important causes of unilateral tonsillar enlargement #ent-prof-written #card
	  id:: 6756d082-fbe1-4362-8a50-35ce92742f7a
	  deck:: #ENT
		- Peritonsillar abscess(Quinsy)
		  logseq.order-list-type:: number
		- Tonsillar malignancy (e.g., lymphoma, squamous cell carcinoma)
		  logseq.order-list-type:: number
		- Atypical infections (e.g., Actinomyces, TB)
		  logseq.order-list-type:: number
	- ### Risk Factors
		- Age : Children (5-15 years)
		- Overcrowding
		- Close contact (schools, daycare)
		- Immunocompromised state
- ## Epidemiology
  background-color:: blue
	- ### Incidence
		- Common in children (5-15 years)
		- Peak incidence : Winter/early spring
	- ### Prevalence
		- ~70-80% of pediatric sore throat cases are viral
		- ~25-30% of pediatric sore throat cases are bacterial(GAS)
		- ### Demographics
			- More common in children (5-15 years, peak at 5-7 years)
			- Less common in adults (but still significant)
	- ### Geographic Distribution
		- Global, but higher in urban areas due to crowding
- ## Pathophysiology
  background-color:: blue
	- ### Mechanism of Disease
		- Viral : Direct mucosal invasion -> inflammation
		- Bacterial(GAS)
			- M protein -> evades phagocytosis
			- Exotoxins -> tissue damage
	- ### Affected Systems/Organs
		- Tonsils & pharynx (prime site)
		- Lymph nodes (reactive enlargement)
		- Systemic (if bacteremia -> rheumatic fever, AGN) | as complication
- ## Clinical Features #ent-prof-card #unanswered #card
  background-color:: blue
  deck:: #ENT
  id:: 6733ccec-0fd5-4d94-a031-50fd073d4404
	- ### Clinical Presentation
		- #### Symptoms
			- Severe sore throat
			  logseq.order-list-type:: number
			- Dysphagia
			  logseq.order-list-type:: number
			- Fever (>38ºC)
			  logseq.order-list-type:: number
			- Odynophagia (painful swallowing)
			  logseq.order-list-type:: number
			- Unable to open mouth (pain)
			  logseq.order-list-type:: number
			- Change of voice
			  logseq.order-list-type:: number
			- Earache (referred pain or the result of acute otitis media as a complication)
			  logseq.order-list-type:: number
		- #### Signs
			- Temperature high (102ºF to 104ºF)
			  logseq.order-list-type:: number
			- Tonsil - swollen, oedematous, congested, pus over the tonsil
			  logseq.order-list-type:: number
			- Jugulo digastric lymph node - enlarged and tender
			  logseq.order-list-type:: number
			- Surrounding soft tissue (pillar, soft palate, uvula) - congested
			  logseq.order-list-type:: number
	- ### Stages or Classification
		- Acute Catarrhal Tonsillitis (mild inflammation)
		- Acute Follicular Tonsillitis (yellowish follicles)
		- Acute Membranous Tonsillitis (pseudomembrane formation)
		- Acute Parenchymatous Tonsillitis (diffuse swelling)
- ## Diagnosis
  background-color:: blue
	- ### Diagnostic Criteria
		- Centor Criteria(for GAS tonsillitis) ≥3
			- Fever > 38ºC
			- Tonsillar exudate
			- Tender Jugulodigastric Lymph node
			- No cough
	- ### Investigations
		- ### Establishing Diagnosis
			- Throat Swab : Rapid Strep Test or throat culture (GAS) and Sensitivity.
			- CBC: Neutrophilic leukocytosis (bacterial) / Lymphocytosis (viral)
		- ### Ruling Out Differential Diagnosis #ent-prof-written #card
		  deck:: #ENT
		- | DD                | Ruling Out                          |  
		            |-------------------|-----------------------------------|  
		            | Infectious mono   | Heterophile antibody test (EBV)   |  
		            | Peritonsillar abscess | Trismus, uvular deviation, CT      |  
		            | Diphtheria        | Grey pseudomembrane, culture       |
		- ### General Assessment
			- Hydration status, airway compromise.
- ## Management and Treatment #ent-prof-card #unanswered #ent-prof-written #card
  background-color:: blue
  deck:: #ENT
  id:: 6733ccec-59ce-49d1-91d1-710b3d517df6
	- ### Medical Treatment
		- Broad spectrum antibiotics: [[Cefixime]] 200 mg / [[Cefuroxime]] 200 mg [[TDS]]
		  _Amoxicillin is 1st line_
			- Macrolides (if penicillin allergy)
		- Supportive Care
			- NSAIDs, Analgesics: [[Ibuprofen]] 
			  *NSAIDs are better than paracetamol for pain[[Paracetamol]]*
			- Antipyretics
			- Hydration
			- Warm Saline gargles
		- Nutrition maintain - liquid and soft solid food should be given
	- ### Surgical Options - [[Tonsillectomy]]
		- if [[Recurrent Tonsillitis]]
			- {{embed ((67ce2433-f27b-4e87-8394-b338c461ee4a))}}
		- if Complications (abscess, obstruction)
	- ### Lifestyle and Dietary Recommendations
		- Hydration (warm fluids)
		- Avoid irritants (smoking, cold drink)
		- Bed rest
	- ### Follow up
		- Re-evaluate if no improvement in 48h
- ## Prognosis
  background-color:: blue
	- ### Expected Course
		- #### With Treatment
			- Bacterial : Improves in 24-48h with antibiotics
		- #### Without Treatment
			- Viral : Self-limiting (3-7 days)
			- ##### Possible Complications #ent-prof-written #card
			  deck:: #ENT
				- #### Local
					- [[Chronic Tonsillitits]]
					- [[Peritonsillar abscess]]
					- [[Retropharyngeal abscess]]
					- [[Airway obstruction]]
				- #### General
					- [[Septicemia]]
					- [[Rheumatic Fever]]
					- [[AGN]]
			- ### Long-term Effects
				- [[Chronic Tonsillitits]]
				- Tonsillar hypertrophy -> Obstructive Sleep Apnea
	- ### Quality of Life Considerations
- ## Prevention
  background-color:: blue
	- ### Health Education
		- Hand Hygiene
		- Avoid Sharing Utensils
	- ### Community Approach
		- Avoid close contact with infected individuals
	- ### Screening Programs
	- ### Lifestyle Modifications
		- Smoking cessation
		- Vaccination (flu, covid) reduces viral cases
- ## Patient Education and Support
  background-color:: blue
	- ### Educational Resources
		- Educate on antibiotic compliance
		- Warning signs (difficulty breathing, drooling -> abscess)
	- ### Support Groups
	- ### Counseling Options
- ## Recent Research and Developments
  background-color:: blue
	- ### Ongoing Clinical Trials
	- ### Recent Advances
- ## Key Literature
  background-color:: blue
- ## Guidelines and Protocols
  background-color:: blue
	- *IDSA (2012)*: Penicillin 1st-line for GAS
	- *NICE (2023)*: Antibiotics only if Centor ≥3